AN AUDIT OF MANAGEMENT OF HEPATITIS B (HBV) AND HEPATITIS C (HCV): STRENGTHS AND WEAKNESSES ANALYSIS
| Main Author: | Dr. Faizan Majeed, Dr. Nouman Anees, Dr. Muhammad Shahroz Khurshid, Dr. Usman Shahzad |
|---|---|
| Format: | Article Journal |
| Bahasa: | eng |
| Terbitan: |
, 2018
|
| Subjects: | |
| Online Access: |
https://zenodo.org/record/1283777 |
Daftar Isi:
- Objectives: The evaluation of treatment response on large-scale cases of Hepatitis B & C in a national level program was the objective of research. Methods: We consulted the records of all the cases treated under the National Hepatitis Prevention Program in the last two years that is 2016 – 2017 at twelve various sites and ensured the confidentiality of the record. We studied, analyzed and assessed the data at Allied Hospital, Faisalabad on all the cases who completed their follow-up and complied with the guidelines and excluded the rest who failed to do so. A special program was developed in order to assess the data. Results: Research sample comprised of 7752 patients who were managed under the said program at twelve various sites. In the sample population six-month treatment was completed by 3440 patients (45.4%); whereas, only 1686 employed polymerase chain reaction test (49%) at the end of 6 months. The infection was not diagnosed in the time of six months in 1133 out of 1686 cases (67%); whereas, no response was observed in 553 cases (33%). Inclusion criteria was completed by a total of 454 cases and management of the disease was carried out in 85 cases (18.72%), complete treatment in 9 cases (10.58%), 3 cases were positive for HBV (3.52%) for clearance of antigen and anti-HBe production. Conclusion: The inappropriate record keeping and poor incidence of follow-up in biochemical/ serological tests was observed as the loop hole in both the infected cases including HBV and HCV. This resulted in the wastage of financial and manpower resources as there was an obvious ill planning and factor of accountability was also missing. Keywords: Viral Infection, Hepatitis B & C, HBV and HCV,